 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] OCI Holdings (010060) announced that it will acquire a 27.03% stake in Hanmi Science (008930) for 770.3 billion won. Hanmi Science is a holding company of Hanmi Pharmaceutical Group.
The acquisition of the stake uses a new share acquisition method through the acquisition of old shares and participation in third-party paid-in capital increase.
For now, OCI Holdings plans to purchase 744,674 ordinary shares of Hanmi Science held by Hanmi Science Chairman Song Young-sook, wife of Hanmi Pharm founder Lim Sung-ki, Lim's grandchildren Kim Won-se and Kim Ji-woo.
In addition, OCI Holdings will receive 1,141,495 shares and 5,634,810 shares in kind held by Chairman Song and Hanmi Science President Lim Joo-hyun. In return, OCI Holdings will issue 2,291,532 ordinary shares through a third-party paid-in capital increase worth 252.8 billion won and issue 386,017 and 1,905,515 shares to Song and Lim, respectively.
Hanmi Science will carry out a third-party allocation paid-in capital increase worth about 240 billion won to OCI Holdings. OCI Holdings will take part in the bequest and acquire 6,434,316 common shares issued by Hanmi Science. Hanmi Science plans to spend 140 billion won on operation and 100 billion won on debt repayment of the funds raised by the bequest.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
